Pharmaceutical Retailers stocks worldwide, ranked

As of 13 Nov 2026, DaShenLin Pharmaceutical Group (603233.SS) ranks first in Pharmaceutical Retailers on MoatMap, with a MoatMap Score of 98/100, among 28 companies in 9 countries worth $200M or more that trade $1M or more a day. A research ranking, not investment advice.

The score reads each company's latest yearly results, so when a whole industry is near the top of its cycle, its companies can rank high together.

Live list, follows each night's scores · scores as of ·How we score stocks

The top 25 Pharmaceutical Retailers companies by MoatMap Score

#StockYieldP/EScoreQVMStyle · Activity
1
603233.SS
DaShenLin Pharmaceutical Group Co., Ltd.
China · $3.2B

Momentum 73: near its 52-week high and outperforming the market over 6 months. Value 72: cheap on free cash flow and a high yield. Quality 72: strong free cash flow and ROIC in the top 10% of its sector.

Yield 4.3%P/E 17.2
98
Score
72
Q
72
V
73
M
Full House
2
3148.T
Create SD Holdings Co., Ltd.
Japan · $1.3B

Value 76: cheap on sales and cheap on EV/EBITDA. Quality 73: interest well covered and high gross profitability. Momentum 66: near its 52-week high.

Yield 2.8%P/E 12.4
98
Score
73
Q
76
V
66
M
Full House
3
3034.T
Qol Holdings Co., Ltd.
Japan · $567.2M

Value 82: cheap on sales and cheap on EV/EBITDA. Momentum 71: outperforming the market over 6 months and above its moving averages. Quality 66: ROIC in the top 15% of its sector and high return on equity.

Yield 1.1%P/E 10.7
98
Score
66
Q
82
V
71
M
Full House
4
002727.SZ
Yixintang Pharmaceutical Group Co., Ltd.
China · $1.1B

Value 74: cheap on sales and cheap on free cash flow. Momentum 73: quarterly earnings growing and estimates revised up. Quality 63: F-Score 9/9 and strong free cash flow.

Yield 1.5%P/E 20.4
97
Score
63
Q
74
V
73
M
Full House
5
603939.SS
Yifeng Pharmacy Chain Co., Ltd.
China · $4.6B

Quality 72: strong free cash flow and ROIC in the top 15% of its sector. Momentum 68: near its 52-week high and outperforming the market over 6 months. Value 66: cheap on free cash flow and cheap on sales.

Yield 2.6%P/E 18.4
96
Score
72
Q
66
V
68
M
Full House
6
603883.SS
LBX Pharmacy Chain Joint Stock Company
China · $1.6B

Value 72: cheap on free cash flow and cheap on sales. Momentum 71: estimates revised up and outperforming the market over 6 months. Quality 63: strong free cash flow and high gross profitability.

Yield 3.8%P/E 24.5
96
Score
63
Q
72
V
71
M
Full House
7
2664.T
Cawachi Limited
Japan · $569.5M

Momentum 79: near its 52-week high and outperforming the market over 6 months. Value 72: cheap on sales and below book value. Quality 58: interest well covered but a tight balance sheet.

Yield 3.1%P/E 30.4
96
Score
58
Q
72
V
79
M
Full House
8
3088.T
MatsukiyoCocokara & Co.
Japan · $6.6B

Quality 75: low debt and interest well covered. Momentum 65: near its 52-week high and outperforming the market over 6 months. Value 65: cheap on sales and cheap on EV/EBITDA.

Yield 1.8%P/E 18.5
95
Score
75
Q
65
V
65
M
Full House
9
9989.T
Sundrug Co.,Ltd.
Japan · $2.7B

Value 70: cheap on sales and cheap on EV/EBITDA. Quality 68: interest well covered and high gross profitability. Momentum 59: near its 52-week high but EPS deteriorating.

Yield 3.4%P/E 13.9
93
Score
68
Q
70
V
59
M
Full House
10
3391.T
Tsuruha Holdings Inc.
Japan · $6.4B

Value 67: cheap on sales and below book value. Momentum 66: outperforming the market over 6 months and quarterly earnings growing. Quality 62: F-Score 7/9 and high gross profitability.

Yield 0.9%P/E 18.5
91
Score
62
Q
67
V
66
M
Full House
11
4164.SR
Nahdi Medical Company
Saudi Arabia · $3.2B

Quality 71: high return on equity and high gross profitability. Value 62: cheap on sales and a high yield. Momentum 60: near its 52-week high.

Yield 3.3%P/E 15.3
90
Score
71
Q
62
V
60
M
Full House
12
7649.T
Sugi Holdings Co.,Ltd.
Japan · $3B

Value 75: cheap on sales and cheap on free cash flow. Quality 72: interest well covered and high gross profitability. Momentum 39: estimates cut.

Yield 1.3%P/E 16.4
86
Score
72
Q
75
V
39
M
Unloved Quality
13
6618.HK
JD Health International Inc.
China · $15.3B

Quality 70: strong free cash flow and interest well covered. Value 58: cheap on free cash flow. Momentum 51: estimates revised up but below its moving averages.

Yield —P/E 19.9
81
Score
70
Q
58
V
51
M
Full House
14
3349.T
COSMOS Pharmaceutical Corporation
Japan · $3.2B

Quality 64: interest well covered and F-Score 7/9. Value 61: cheap on sales and cheap on EV/EBITDA. Momentum 53: estimates revised up but EPS deteriorating.

Yield 1.2%P/E 15.6
80
Score
64
Q
61
V
53
M
Full House
15
CLS.JO
Clicks Group Limited
South Africa · $3B

Quality 72: ROIC in the top 5% of its sector and high return on equity. Value 60: a high yield and cheap on sales. Momentum 46: estimates revised up but below its moving averages.

Yield 4.1%P/E 15.5
80
Score
72
Q
60
V
46
M
Unloved Quality
16
9627.T
Ain Holdings Inc.
Japan · $1.3B

Value 78: cheap on sales and cheap on EV/EBITDA. Momentum 52: estimates revised up but EPS deteriorating. Quality 48: interest well covered but a tight balance sheet.

Yield 1.7%P/E 11.2
80
Score
48
Q
78
V
52
M
Second Wind
17
APOTEA.ST
Apotea AB (publ)
Sweden · $952.8M

Momentum 74: above its moving averages and near its 52-week high. Quality 73: ROIC in the top 5% of its sector and high gross profitability. Value 26: far above book value.

Yield 0.6%P/E 41.9
76
Score
73
Q
26
V
74
M
Premium GrowerDir. buy $86K
18
3549.T
Kusuri No Aoki Holdings Co., Ltd.
Japan · $2.6B

Momentum 72: near its 52-week high and outperforming the market over 6 months. Quality 54: high return on equity but high debt. Value 42: cheap on sales but expensive on free cash flow.

Yield 0.3%P/E 24.6
72
Score
54
Q
42
V
72
M
Premium Grower
19
301408.SZ
Anhui Huaren Health Pharmaceutical Co., Ltd.
China · $815.6M

Quality 69: F-Score 8/9 and strong free cash flow. Value 62: cheap on free cash flow and cheap on sales. Momentum 36: below its moving averages.

Yield 0.7%P/E 21.9
71
Score
69
Q
62
V
36
M
Unloved Quality
20
PGMN3.SA
Empreendimentos Pague Menos S.A.
Brazil · $779.3M

Value 81: cheap on sales and a high yield. Quality 59: high gross profitability but high debt. Momentum 24: estimates cut.

Yield 10.2%P/E 5.0
67
Score
59
Q
81
V
24
M
Unloved QualityDir. buy $8KDir. sell $111K
21
9267.T
Genky DrugStores Co., Ltd.
Japan · $657.7M

Value 60: cheap on sales and cheap on EV/EBITDA. Quality 52: high return on equity but a tight balance sheet. Momentum 49: estimates revised up but EPS deteriorating.

Yield 0.3%P/E 14.7
64
Score
52
Q
60
V
49
M
Unloved Quality
22
0241.HK
Alibaba Health Information Technology Limited
Hong Kong · $5.9B

Quality 71: low debt and interest well covered. Value 52: a high yield. Momentum 33: estimates cut.

Yield 7.3%P/E 23.8
60
Score
71
Q
52
V
33
M
Unloved QualityDir. buy $22K
23
DOCM.SW
DocMorris AG
Switzerland · $949.6M

Momentum 82: outperforming the market over 6 months and above its moving averages. Quality 39: high debt. Value 36: expensive on EV/EBITDA.

Yield —P/E —
60
Score
39
Q
36
V
82
M
Hot Air
24
002788.SZ
Luyan Pharma Co.,Ltd.
China · $568.5M

Value 75: cheap on sales and cheap on free cash flow. Quality 47: ROIC in the top 20% of its sector but high debt. Momentum 29: well off its 52-week high.

Yield 3.6%P/E 13.6
56
Score
47
Q
75
V
29
M
Bargain Bin
25
301017.SZ
ShuYu Civilian Pharmacy Corp., Ltd.
China · $859.8M

Quality 57: F-Score 8/9 but a tight balance sheet. Momentum 52: outperforming the market over 6 months. Value 42: cheap on free cash flow but expensive on P/E.

Yield 0.3%P/E 239
55
Score
57
Q
42
V
52
M
Premium Grower

Ranked by MoatMap Score, the 0 to 100 score of Quality, Value and Momentum, among companies worth $200M or more that trade $1M or more a day, one line per company. Director dealings are director purchases and sales filed in the last 180 days, where MoatMap carries the market's filings.